help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on October 4, 2005
Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2005-1357
A more recent version of this article appeared on December 1, 2005
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
90/12/6386    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Roth, C. L.
Right arrow Articles by Reinehr, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Roth, C. L.
Right arrow Articles by Reinehr, T.

Submitted on June 20, 2005
Accepted on September 27, 2005

Peptide YY is a regulator of energy homeostasis in obese children before and after weight loss

Christian L. Roth*, Pablo J. Enriori, Katia Harz, Joachim Woelfle, Michael A. Cowley, and Thomas Reinehr

Department of Pediatrics, University of Bonn, Germany; Division of Neurosciences, Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, USA; Vestische Children Hospital Datteln, University of Witten/Herdecke, Germany

* To whom correspondence should be addressed. E-mail: croth{at}uni-bonn.de.

Context: The gut hormone peptide YY3-36 (PYY) reduces food intake via hypothalamic Y2 receptors in the brain. There is not much known about PYY in obese children.

Objective: To investigate the role of PYY in the metabolic changes of obese children and its change in weight loss.

Setting: University Medical Center.

Participants: 73 obese children and 45 age-matched normal weight children.

Interventions: We determined fasting serum total PYY and leptin by RIA in obese and normal weight children. Fasting PYY was also measured in 28 obese children before and after completion of a 1-year outpatient weight reduction program.

Main outcome measures: PYY, insulin, BMI.

Results: Obese children demonstrated significantly lower PYY levels vs. lean children (median 67pg/ml vs. 124pg/ml, P < 0.001). Fasting PYY correlated negatively to the degree of overweight. PYY levels did not differ significantly between boys and girls, nor between prepubertal and pubertal children. The group of patients participating in the outpatient weight reduction program was divided into four quartiles according to their changes in SDS-BMI over a 1-year period. PYY increased significantly in patients with the most effective weight loss, but decreased in the subgroup of children with weight gain.

Conclusions: PYY is negatively correlated to the degree of overweight with reduced values in obese compared with normal weight children. Decreased PYY levels could predispose subjects to develop obesity. Our results indicate low pretreatment PYY levels that increase during weight loss may be a predictor of maintained weight loss.


Key words: Childhood obesity • Peptide YY • weight reduction treatment




This article has been cited by other articles:


Home page
J. Physiol.Home page
E. Karra, K. Chandarana, and R. L. Batterham
The role of peptide YY in appetite regulation and obesity
J. Physiol., January 1, 2009; 587(1): 19 - 25.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
V. Hainer, H. Toplak, and A. Mitrakou
Treatment Modalities of Obesity: What fits whom?
Diabetes Care, February 1, 2008; 31(Supplement_2): S269 - S277.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
L. J Moran, M. Noakes, P. M Clifton, G. A Wittert, C. W Le Roux, M. A Ghatei, S. R Bloom, and R. J Norman
Postprandial ghrelin, cholecystokinin, peptide YY, and appetite before and after weight loss in overweight women with and without polycystic ovary syndrome
Am. J. Clinical Nutrition, December 1, 2007; 86(6): 1603 - 1610.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
A. M. van den Hoek, A. C. Heijboer, P. J. Voshol, L. M. Havekes, J. A. Romijn, E. P. M. Corssmit, and H. Pijl
Chronic PYY3-36 treatment promotes fat oxidation and ameliorates insulin resistance in C57BL6 mice
Am J Physiol Endocrinol Metab, January 1, 2007; 292(1): E238 - E245.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J.-P. Chanoine
Individual Differences in the Hormonal Control of Appetite: A Step toward a (More) Successful Treatment of Childhood Overweight?
J. Clin. Endocrinol. Metab., August 1, 2006; 91(8): 2864 - 2866.
[Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
R. Morinigo, V. Moize, M. Musri, A. M. Lacy, S. Navarro, J. L. Marin, S. Delgado, R. Casamitjana, and J. Vidal
Glucagon-Like Peptide-1, Peptide YY, Hunger, and Satiety after Gastric Bypass Surgery in Morbidly Obese Subjects
J. Clin. Endocrinol. Metab., May 1, 2006; 91(5): 1735 - 1740.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
O. B. Chaudhri, B. C. T. Field, and S. R. Bloom
From gut to mind--hormonal satiety signals and anorexia nervosa.
J. Clin. Endocrinol. Metab., March 1, 2006; 91(3): 797 - 798.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2005 by The Endocrine Society